Age-Related Macular Degeneration

Bausch + Lomb acquired Whitecap Biosciences, including its two therapies for potential use in glaucoma and geographic atrophy, to strengthen its clinical-stage pipeline, according to a press release.

CHICAGO — In this video, Clement K. Chan, MD, FACS, discusses highlights from the AAO meeting, including presentations on pegcetacoplan and avacincaptad pegol for the treatment of geographic atrophy.

Character Biosciences announced a collaboration with Bausch + Lomb with an initial focus on developing innovative treatments for age-related macular degeneration, according to a press release.

CHICAGO — In this video, Clement K. Chan, MD, FACS, discusses a presentation from the AAO meeting on multimodal imaging to assess geographic atrophy.

At CES 2025, Soliddd, an optical and vision technology company, will debut the beta headset version of its virtual reality smart glasses for people with vision loss related to age-related macular degeneration, according to a press release.

Some megatrends in health care are occurring that deserve our attention.

Assistive visual technology can be an important tool for fostering independence in the low vision community.

The data and safety monitoring board for a phase 1/2 study clinical trial of a geographic atrophy gene therapy approved continuation of the second phase of the study due to positive safety results, according to a press release from Ocugen.

In 2024, Healio covered several stories about trials investigating geographic atrophy biomarkers and treatment options.

Large retrospective studies have demonstrated that visual impairment is a risk factor for developing cognitive impairment, including dementia.